Do not source unlicensed peptides online
The pattern seen with rapid weight loss is telogen effluvium, a temporary, non-scarring shedding
Conclusions In summary, this study provides comprehensive mechanistic insights into how Retatrutide, a triple agonist of the GIP, GLP-1, and glucagon receptors, exerts potent anti-obesity and metabolic benefits through coordinated molecular and metabolic remodeling of adipose tissue
This benefit appeared independent of weight loss, suggesting direct cardiovascular protective effects from GLP-1 receptor activation
By activating all three pathways simultaneously, Retatrutide addresses appetite, insulin sensitivity, AND energy expenditure at the same time
Dose titration is important because retatrutide can cause gastrointestinal side effects, especially when doses are increased too quickly